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Whilst screening various cell lines for their ability to respond to interferon (IFN), we noted that in comparison to other tissue culture cells AGS
tumour cells, which are widely used in biomedical research, had very low levels of STAT1. Subsequent analysis showed that the reason for this is
that AGS cells are persistently infected with parainfluenza virus type 5 (PIV5; formally known as SV5), a virus that blocks the interferon (IFN)
response by targeting STAT1 for proteasome-mediated degradation. Virus protein expression in AGS is altered in comparison to the normal pattern
of virus protein synthesis observed in acutely infected cells, suggesting that the AGS virus is defective. We discuss the relevance of these results in
terms of the need to screen cell lines for persistent virus infections that can alter cellular functions.
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During screening of a variety of cell lines for their interferon
(IFN) response we noted that, compared to other tissue culture
cells, AGS cells (a cell line widely used in biomedical research;
supplied to us by Dr K. Mellits, University of Nottingham, UK)
had extremely low levels of STAT1. Indeed, immunoblots had
to be overexposed (as defined by other cell lines) to visualise
STAT1 in AGS cells (Fig. 1a). Furthermore, given that STAT1 is
inducible by IFN, it was noticeable that the levels of STAT1 did
not increase upon the addition of exogenous IFN to the culture
medium, suggesting that AGS cells have an IFN signalling
defect. However, given our work on how the V protein of
parainfluenza virus type 5 (PIV5; formally known as SV5)
targets STAT1 for proteasome-mediated degradation (Didcock
et al., 1999; reviewed in Horvath, 2004; Stock et al., 2005), and
on the ability of PIV5 to establish persistent infections
(Chatziandreou et al., 2002), we were aware that the low levels
of STAT1 in AGS cells may be because the cells were
persistently infected with PIV5. Furthermore, it is known that⁎ Corresponding author. Fax: +44 1334 463397.
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doi:10.1016/j.virol.2007.03.061PIV5 can also contaminate laboratory cell cultures (Hsiung,
1972). To address whether AGS cells were infected with PIV5,
AGS cells were stained with monoclonal antibodies to NP and P
proteins of PIV5. As can be seen in Fig. 1b, the AGS cells were
clearly positive for the NP and P proteins. Interestingly, whilst
N95% of AGS cells were clearly positive for virus antigen, a
small proportion of cells were either weakly positive or
appeared negative (highlighted by an arrow in Fig. 1b). The
reason why some cells are only weakly positive/negative is
currently unclear, but these cells may contain some STAT1
thereby explaining the very low levels of STAT1 that can be
detected in AGS cells (Fig. 1a, section ii).
To rule out the possibility that we could have accidentally
infected these cells within our laboratory, AGS cells were
obtained from ECACC and ATCC and these too were infected.
Next we contacted the laboratory (Dr C.M. Townsend and Dr
M.R. Hellmich, University of Texas, Galveston, USA) where
the AGS cells were originally isolated (Barranco et al., 1983a)
and they kindly sent us two separate cell lines, the original
uncloned parental cell line (AGS-P) and a daughter line termed
AGS clone 10; the latter being subsequently deposited with
ATCC. Our analysis revealed that AGS-P cells (which were not
deposited at ATCC or ECACC) were not infected with PIV5
(Fig. 1c). Furthermore, these cells could respond to IFN as
Fig. 1. Panel (a) Immunoblot detection of STAT1 in AGS and Vero cells that had, or had not, been treated with IFN for 16 h (immunoblot ii is a longer exposure of
immunoblot i). Panel (b) Immunofluorescence detection of the NP and P proteins in Vero cells that had, or had not (Mock), been infected with PIV5 for 24 h, or in AGS
cells (note the area of AGS cells (arrowed) which show relatively low levels of viral proteins). Panel (c) Immunoblot detection of STAT1, STAT2, actin and the NP, P
and V proteins of PIV5 in mock-infected or PIV5-infected Vero cells (24 h p.i.), and in AGS-P and AGS-10 cells. Cells were, or were not, treated with IFN for 16 h
prior to harvesting for immunoblot analysis. Panel (d) Detection of PIV5 proteins in total cell extracts, and in immune precipitates, of AGS cells, and in Vero cells that
had, or had not (Mock), been infected with PIV5 for 16 h. Cells were metabolically labelled with [35S]-methionine for 1 h and the viral proteins were immune
precipitated with a pool of mAbs as previously described (Carlos et al., 2005). The labelled proteins were separated by SDS–PAGE and visualized by phosphorimager
analysis. Panel (e) Immunoblot detection of the HN and M proteins in total cell extracts of AGS-10 cells and of mock-infected or PIV5-infected Vero cells (at 16 h post
infection). Details of the antibodies used and the methods for immunoprecipitation and immunofluorescence are described in Carlos et al. (2005), Didcock et al.
(1999), Randall et al. (1987).
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treatment of the cells with IFN (Fig. 1c). In stark contrast, the
AGS clone 10 cells were persistently infected with PIV5 and
could not respond to IFN.
Although AGS clone 10 cells, and derivatives, are infected
with PIV5, they show no obvious cytopathic effects and only
release very low levels of infectious virus into the cultured
medium (b10 pfu/ml of culture medium), demonstrating that
the virus must be defective. This conclusion was supported
by the observation that the pattern of virus protein synthesis
observed in AGS cells was very different from that in acutely
infected cells. In particular, there was a reduction in the
overall level of HN and M protein synthesis in relation to NP
and P (Fig. 1d). Furthermore, immunoblot analysis revealed
that the overall levels of M in AGS cells was extremely low
compared to acutely infected cells and that the HN protein
was poorly glycosylated (Fig. 1f). To characterize the AGS
virus further, we next compared nucleotide and derived
amino acid sequences of the P, V, M and F genes of the AGS
virus with the respective sequences of other PIV5 isolates.
These results (data not shown) showed that the AGS virus
was most closely related to human isolates of PIV5 (DEN,
MIL, MEL, LN), and that there was b4% amino acid
difference in the derived sequence compared to all the other
isolates of PIV5 that have been sequenced (Chatziandreou et
al., 2004).AGS cells were derived from a human gastric adenocarci-
noma (Barranco et al., 1983a,1983b) and are widely used in
biomedical research. There are over 300 scientific publications
in which AGS cells have been used for studies ranging from
growth regulation of stomach-cancer cells, drug induced anti-
inflammatory effects and apoptosis, the interaction of Helico-
bacter pylori on gastric epithelial cells and IFN responses of
gastric adenocarcinoma cells. A defect in IFN signalling and the
low levels of STAT1 in AGS cells have previously been
published, and it has been speculated that this lack of
responsiveness to IFN may contribute to tumour formation
(Abril et al., 1996, 1998). However, surprisingly in light of our
studies, in some publications using AGS cells, STAT1 was
detected and the cells responded to IFN, e.g. Mitchell et al.,
2004. Since these results would not be possible if the cells were
infected with PIV5, it suggests that (i) there are a small number
of uninfected cells in the AGS cells used that can respond to
IFN (as shown in Figs. 1a and b), (ii) there must be different
clones of AGS cells within the scientific community (although
the original cells sent to ATCC were infected with PIV5), or iii)
that not all cells that are thought to be AGS cells are indeed
AGS cells. In this latter regard, it is of note that cross-
contamination of cell lines is relatively common (Stacey et al.,
1992). We are also aware that other cell lines, including an
oligodendrocyte cell line, have become persistently infected
with PIV5 (Thorsten Wolff, personal communication; Robert
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(paramyxo)virus that can establish persistent infections in tissue
culture whilst severely affecting cellular functions. It is
therefore important for the scientific community to be aware
that cells may be persistently infected with viruses, such as
PIV5, that can significantly alter cellular physiology. Indeed, in
light of these results, some of the conclusions drawn from
previous studies that used AGS cells may have to be re-
evaluated, especially as not only does the V protein of PIV5
target STAT1 for degradation, but it also binds to, and inhibits
the activity of, mda-5, a cellular protein that recognises dsRNA
and activates the IFN induction cascade (Andrejeva et al., 2004;
Childs et al., 2007).
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